Insmed (INSM) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $120.82 -0.15%
EPS Growth %: +77.7%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +77.7%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.80), $0.08 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $53.1 million versus the consensus estimate of $53.39 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
